Pages that link to "Q73446663"

The following pages link to Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients (Q73446663):

Displaying 13 items.

• The role of CD95 and CD95 ligand in cancer (Q26995847) (← links)
• Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis (Q33323694) (← links)
• EPMA position paper in cancer: current overview and future perspectives (Q35532215) (← links)
• MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line (Q36312729) (← links)
• Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas (Q36464307) (← links)
• MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients (Q36698880) (← links)
• Tissue microarray analysis of Fas and FasL expressions in human non-small cell lung carcinomas; with reference to the p53 and bcl-2 overexpressions (Q37425678) (← links)
• Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables (Q37929588) (← links)
• Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer (Q44583968) (← links)
• Characteristics of long-term survivors of untreated lung cancer. (Q53971075) (← links)
• Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer (Q59219447) (← links)
• Sirt1 protects from K-Ras-driven lung carcinogenesis (Q90320971) (← links)
• In silico analysis of the prognostic value of FAS mRNA in malignancies (Q92669969) (← links)